Page 35 - Global Pharmaceuticals & Biotech Dividend Stocks

UPDATED Aug 20, 2025

Discover Global Pharmaceuticals & Biotech High Yield Dividend Stocks from around the world and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on 'Advanced Filters'.

893 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
688506
Sichuan Biokin PharmaceuticalLtd
CN¥311.82-0.2%75.3%CN¥125.0bCN¥314.67PE33.7xE-119.0%0%
NECLIFE
Nectar Lifesciences
₹15.08-1.0%-59.6%₹3.4bn/aPB0.4xn/a0%
530239
Suven Life Sciences
₹235.151.8%59.5%₹51.3bn/aPS682.9xn/a0%
VIT
Vitura Health
AU$0.0711.4%-5.3%AU$47.0mn/aPE24.2xn/a0%
688091
Shanghai Yizhong Pharmaceutical
CN¥72.37-6.6%178.3%CN¥14.9bn/aPE1419.9xn/a0%
688265
Shanghai Model Organisms Center
CN¥61.5017.9%192.4%CN¥4.7bn/aPE252.4xn/a0%
PPGN
PolyPeptide Group
CHF 28.8510.3%-11.1%CHF 951.8mCHF 31.30PS2.8xE88.0%0%
REKA
Rekah Pharmaceutical Industry
₪11.93-0.7%-12.3%₪136.2mn/aPE52.5xn/a0%
AMRX
Amneal Pharmaceuticals
US$9.410.1%15.6%US$2.9bUS$12.00PE875.7xE80.6%0%
GX1
genXone
zł5.50-11.6%-12.1%zł18.2mn/aPS9.6xn/a0%
HLS
HLS Therapeutics
CA$5.12-0.2%58.5%CA$162.0mCA$6.46PS2.1xE58.9%0%
INAF
Indofarma
Rp126.000%-74.3%Rp390.5bn/aPS1.4xn/a0%
DADI
Dar Al Dawa Development and Investment
د.أ1.180.9%-7.8%د.أ41.3mn/aPE10xn/a0%
A092040
Amicogen
₩3,645.00-6.1%-27.7%₩199.8bn/aPS1.3xn/a0%
688319
Chengdu Olymvax Biopharmaceuticals
CN¥33.1137.8%288.2%CN¥13.4bCN¥27.55PE338.7xE16.5%0%
2693
Hainan Shuangcheng Pharmaceuticals
CN¥8.281.2%67.3%CN¥3.4bn/aPS21xn/a0%
A017180
MYUNGMOON PharmLtd
₩1,681.004.3%-26.9%₩56.2bn/aPE46.3xn/a0%
524470
Syncom Formulations (India)
₹17.44-1.3%-8.7%₹16.4bn/aPE28.5xn/a0%
775
CK Life Sciences Int'l. (Holdings)
HK$0.970%185.3%HK$9.3bn/aPS1.7xn/a0%
300255
Hebei Changshan Biochemical Pharmaceutical
CN¥48.08-0.5%414.2%CN¥44.2bn/aPS44.4xn/a0%
300267
Hunan Er-Kang Pharmaceutical
CN¥4.05-1.2%81.6%CN¥8.4bn/aPS6.9xn/a0%
1312
Kontafarma China Holdings
HK$0.031-6.1%-6.1%HK$173.2mn/aPB0.2xn/a0%
600594
Guizhou Yibai Pharmaceutical
CN¥4.557.6%48.7%CN¥3.6bn/aPS1.7xn/a0%
2022
Shanghai Kehua Bio-EngineeringLtd
CN¥7.47-3.5%27.9%CN¥3.7bn/aPS2.2xn/a0%
Page 35 of 38